Chemoinformaics analysis of 1,4-DIHYDROXY-2-CARBOETHOXYANTHRAQUINONE
Molecular Weight | 312.277 | nRot | 2 |
Heavy Atom Molecular Weight | 300.181 | nRig | 19 |
Exact Molecular Weight | 312.063 | nRing | 3 |
Solubility: LogS | -4.339 | nHRing | 0 |
Solubility: LogP | 3.592 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
nHA | 6 | APOL | 41.2035 |
nHD | 2 | BPOL | 16.3785 |
QED | 0.5 |
Synth | 2.556 |
Natural Product Likeliness | 0.771 |
NR-PPAR-gamma | 0.954 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.394 |
Pgp-sub | 0 |
HIA | 0.013 |
CACO-2 | -5.049 |
MDCK | 0.0000203 |
BBB | 0.007 |
PPB | 1.00078 |
VDSS | 0.348 |
FU | 0.0117817 |
CYP1A2-inh | 0.973 |
CYP1A2-sub | 0.127 |
CYP2c19-inh | 0.43 |
CYP2c19-sub | 0.077 |
CYP2c9-inh | 0.779 |
CYP2c9-sub | 0.465 |
CYP2d6-inh | 0.7 |
CYP2d6-sub | 0.176 |
CYP3a4-inh | 0.426 |
CYP3a4-sub | 0.093 |
CL | 5.766 |
T12 | 0.184 |
hERG | 0.008 |
Ames | 0.929 |
ROA | 0.232 |
SkinSen | 0.625 |
Carcinogencity | 0.637 |
EI | 0.94 |
Respiratory | 0.104 |
NR-Aromatase | 0.733 |
Antiviral | Yes |
Prediction | 0.801414 |